STING, a promising target for small molecular immune modulator: A review

Yijun Liu,Xin Lu,Nan Qin,Yuting Qiao,Shuaishuai Xing,Wenyuan Liu,Feng Feng,Zongliang Liu,Haopeng Sun

DOI: https://doi.org/10.1016/j.ejmech.2020.113113

IF: 7.088

2021-02-01

European Journal of Medicinal Chemistry

Abstract:<p>Stimulator of interferon genes (STING) plays a crucial role in human innate immune system, which is gradually concerned following the emerging immunotherapy. Activated STING induces the production of type I interferons (IFNs) and proinflammatory cytokines through STING-TBK1-IRF3/NF-κB pathway, which could be applied into the treatment of infection, inflammation, and tumorigenesis. Here, we provided a detailed summary of STING from its structure, function and regulation. Especially, we illustrated the canonical or noncanonical cyclic dinucleotides (CDNs) and synthetic small molecules for STING activation or inhibition and their efficacy in related diseases. Importantly, we particularly emphasized the discovery, development and modification of STING agonist or antagonist, attempting to enlighten reader's mind for enriching small molecular modulator of STING. In addition, we summarized biological evaluation methods for the assessment of small molecules activity.</p>

chemistry, medicinal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the potential of STING (stimulator of interferon genes) as a small - molecule immunomodulator. Specifically, the paper mainly focuses on the following aspects:

1. **Structure, function and regulatory mechanism of STING**: The paper comprehensively summarizes the molecular structure of STING, its intracellular localization and how it activates downstream signaling pathways (such as STING - TBK1 - IRF3/NF - κB) by interacting with upstream DNA sensors (such as cGAS) to induce the production of type I interferons (IFNs) and pro - inflammatory cytokines.

2. **Role of STING in infection, inflammation and cancer**: The paper emphasizes the importance of STING in various diseases. For example, in infectious diseases, STING can recognize abnormal DNA and initiate antiviral immune responses; in auto - inflammatory diseases, over - active STING may lead to chronic inflammation; and in cancer, activation of STING can enhance anti - tumor immune responses.

3. **Discovery and development of STING agonists and antagonists**: The paper particularly emphasizes the discovery, development and modification of STING agonists or antagonists, aiming to provide new ideas and directions for the research of small - molecule immunomodulators. This includes the activation or inhibition of STING by naturally occurring cyclic dinucleotides (CDNs) and synthetic small - molecule compounds and their effects in the treatment of related diseases.

4. **Biological activity evaluation methods**: The paper also summarizes the biological evaluation methods used to assess the activity of small molecules to ensure the effectiveness and safety of these compounds.

In summary, this paper aims to comprehensively analyze STING as a potential small - molecule immunomodulatory target and provide theoretical basis and technical support for future research and development.